Synlett 2015; 26(06): 785-790
DOI: 10.1055/s-0034-1380120
letter
© Georg Thieme Verlag Stuttgart · New York

Copper-Catalyzed Tandem Reactions of 2-Iodobenzamides with Sodium Azide: An Efficient Synthesis of [1,2,3]Triazolo[1,5-a][1,4]-benzodiazepin-6(5H)-ones

Wanli Chen
a   Center of Analysis & Measurement, Zhejiang University of Technology, Hangzhou 310014, P. R. of China,
,
Haitao Li
a   Center of Analysis & Measurement, Zhejiang University of Technology, Hangzhou 310014, P. R. of China,
,
Xiaoling Gu
a   Center of Analysis & Measurement, Zhejiang University of Technology, Hangzhou 310014, P. R. of China,
,
Yinghong Zhu*
b   College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, P. R. of China   Email: yhzhuchem@zjut.edu.cn
› Author Affiliations
Further Information

Publication History

Received: 28 November 2014

Accepted after revision: 27 December 2014

Publication Date:
05 February 2015 (online)


Abstract

Copper-catalyzed tandem reactions between 2-iodobenzamides with a propargyl group on the nitrogen atom moiety and sodium azide are presented, providing an efficient method for the synthesis of 3-substituted [1,2,3]triazolo[1,5-a][1,4]benzodiazepin-6(5H)-ones under mild conditions in moderate yields.

Supporting Information

 
  • References and Notes

    • 1a Kaneko T, Wong H, Doyle TW, Rose WC, Bradner WT. J. Med. Chem. 1985; 28: 388
    • 1b Zhang W, William JP, Lu Y, Nagashima T, Chu Q. Tetrahedron Lett. 2007; 48: 563
    • 1c Keenam RM, Callaham JF, Samanen JM, Bondinell WE, Calvo RR, Chen I, DeBrosse C, Eggleston DS, Haltiwanger RC, Hwang SM, Jakes DR, Ku TW, Miller WH, Newlander KA, Nichols A, Parker MF, Southhall LS, Uzinskas I, Vasko-Moser JA, Venslavsky JW, Wong AS, Huffmann WF. J. Med. Chem. 1999; 42: 545
    • 1d Novelli F, Sparatore A, Tass B, Sparatore F. Bioorg. Med. Chem. Lett. 1999; 9: 3031
    • 1e Sugimori T, Okawa T, Eguchi S, Kakehi A, Yashima E, Okamoto Y. Tetrahedron 1998; 54: 7997
    • 1f Walser A, Fryer RI. Bicyclic Diazepines, In Chemistry of Heterocyclic Compounds, . Taylor EC, Weissberger A. Wiley; Chichester: 1991. Part 431, Vol. 50 Chap. V-VIII
    • 2a Roger-Evans M, Spurr P, Hennig M. Tetrahedron Lett. 2003; 44: 2425
    • 2b Broggini G, Orlandi M, Turconi A, Zoni C. Org. Prep. Proced. Int. 2003; 35: 609
    • 2c Broggini G, Molteni G, Terraneo A, Zecchi G. Tetrahedron 1999; 55: 14803
    • 2d Gu Z.-Q, Wong G, Dominguez C, de Costa BR, Rice KC, Skolnick P. J. Med. Chem. 1993; 36: 1001
  • 3 Ogawa K, Matsushita Y. Chem. Pharm. Bull. 1992; 40: 2442
  • 4 Donohue AR, Dannals RF. Tetrahedron Lett. 2009; 50: 7271
    • 5a Basolo L, Beccalli EM, Borsini E, Gianluigi Broggini G, Maisaa Khansaa M, Rigamonti M. Eur. J. Org. Chem. 2010; 1694
    • 5b Patel N, Chambers CS, Hemming K. Synlett 2009; 3043
    • 5c Broggini G, Marchi ID, Martinelli M, Paladino G, Pilati T, Terraneo A. Synthesis 2005; 2246
    • 5d Hunkeler W. Chimia 1993; 47: 141
    • 6a Sahoo S, Veliyath SK, Mahendra Kumar CB. Int. J. Res. Pharm. Sci. 2012; 3: 326
    • 6b Majumdar KC, Ray K. Synthesis 2011; 3767
    • 6c Genin MJ, Allwine DA, Anderson DJ, Barbachyn MR, Emmert DE, Garmon SA, Graber DR, Grege KC, Hester JB, Hutchinson DK, Morris J, Reischer RJ, Ford CW, Zurenko GE, Hamel JC, Schaadt RD, Stapert D, Yagi BH. J. Med. Chem. 2000; 43: 953
    • 6d Palhagen S, Canger R, Henriksen O, van Parys JA, Riviere M.-E, Karolchyk MA. Epilepsy Res. 2001; 43 115
    • 6e Fan WQ, Katritzky AR In Comprehensive Heterocyclic Chemistry II . Vol. 4. Katritzky AR, Rees CW, Scriven EF. V. Elsevier; Oxford: 1996: 1-26
    • 6f Alvarez R, Velásquez S, San-Félix A, Aquaro S, De Clercq E, Perno C.-F, Karlsson A, Balzarini J, Camarasa MJ. J. Med. Chem. 1994; 37: 4185
    • 7a Majumdar KC, Ganai S. Synthesis 2013; 45: 2619
    • 7b Thomas AW. Bioorg. Med. Chem. Lett. 2002; 12: 1881
    • 7c Alajarin M, Cabrera J, Pastor A, Villalgordo JM. Tetrahedron Lett. 2007; 48: 3495
    • 7d Akritopoulou-Zanze I, Gracias V, Djuric SW. Tetrahedron Lett. 2004; 45: 8439
    • 7e Coffen DL, Fryer RI, Katonak DA, Wong F. J. Org. Chem. 1975; 40: 894
    • 7f Broggini G, Molteni G, Terraneo A, Zecchi G. Tetrahedron 1999; 55: 14803
    • 7g Broggini G, DeMarchi I, Martinelli M, Paladino G, Pilati T, Terraneo A. Synthesis 2005; 2246
  • 8 Chowdhury C, Sasmal AK, Achari B. Org. Biomol. Chem. 2010; 8: 4971
  • 9 Broggini G, Molteni G, Zecchi G. Synthesis 1995; 647

    • For reviews about CuAAC reactions and its applications, see:
    • 10a Agalave SG, Maujan SR, Pore VS. Chem. Asian J. 2011; 6: 2696
    • 10b Aragão-Leoneti V, Campo VL, Gomes AS, Field RA, Carvalho I. Tetrahedron 2010; 66: 9475
    • 10c Franc G, Kakkar AK. Chem. Soc. Rev. 2010; 39: 1539
    • 10d Iha RK, Wooley KL, Nyström AM, Burke DJ, Kade MJ, Hawker CJ. Chem. Rev. 2009; 109: 5620
    • 10e Amblard F, Cho JH, Schinazi RF. Chem. Rev. 2009; 109: 4207
    • 10f Meldal M, Tornøe CW. Chem. Rev. 2008; 108: 2951

      For some recent reviews about copper-catalyzed Ullmann-type coupling reactions, see:
    • 11a Ley SV, Thomas AW. Angew. Chem. Int. Ed. 2003; 42: 5400
    • 11b Beletskaya IP, Cheprakov AV. Coord. Chem. Rev. 2004; 248: 2337
    • 11c Evano G, Blanchard N, Toumi M. Chem. Rev. 2008; 108: 3054
    • 11d Monnier F, Taillefer M. Angew. Chem. Int. Ed. 2009; 48: 6954
    • 11e Ma D, Cai Q. Acc. Chem. Res. 2008; 41: 1450
    • 11f Surry DS, Buchwald SL. Chem. Sci. 2010; 1: 13

      For some selected examples, see:
    • 12a Feldman AK, Colasson B, Fokin VV. Org. Lett. 2004; 6: 3897
    • 12b Alonso F, Moglie Y, Radivoy G, Yus M. J. Org. Chem. 2011; 76: 8394
    • 12c Li W.-T, Wu W.-H, Tang C.-H, Tai R, Chen S.-T. ACS Comb. Sci. 2011; 13: 72
    • 12d Attanasi OA, Favi G, Filippone P, Mantellini F, Moscatelli G, Perrulli FR. Org. Lett. 2010; 12: 468
    • 12e Reddy PS, Sreedhar B. Synthesis 2009; 4203
    • 12f Kumar D, Reddy VB, Varma RS. Tetrahedron Lett. 2009; 50: 2065
    • 12g Ackermann L, Potukuchi HK, Landsberg D, Vicente R. Org. Lett. 2008; 10: 3081
    • 12h Yan J, Zhou F, Qin D, Cai T, Ding K, Cai Q. Org. Lett. 2012; 14: 1262
    • 12i Cai Q, Yan J, Ding K. Org. Lett. 2012; 14: 3332
  • 14 3,5-Diphenyl-4H-benzo[f][1,2,3]triazolo[1,5-a][1,4]-diazepin-6(5H)-one (4a); Typical Procedure 2-Iodobenzamides 5 (0.3 mmol), NaN3 (0.36 mmol), CuI (0.03 mmol), N,N′-dimethylethylenediamine (0.06 mmol), and DMSO (1 mL) and H2O (0.2 mL) were added into a Schlenk tube at r.t. under N2. The reaction mixture was stirred at 90 °C until the reaction was complete, as monitored by TLC. Then the reaction mixture was cooled, H2O was added, the aqueous layer was extracted with CH2Cl2 (3 × 20 mL), and dried over MgSO4. After filtration and removal of the solvent in vacuo, the residues were purified with flash chromatography (silica gel; PE–EtOAc, 4:1 v/v) to afford 4 as a yellow solid; mp 208–210 °C. 1H NMR (500 MHz, CDCl3): δ = 8.19 (d, J = 7.7 Hz, 1 H), 8.12 (d, J = 8.0 Hz, 1 H), 7.78 (t, J = 7.4 Hz, 1 H), 7.63 (t, J = 7.6 Hz, 1 H), 7.45–7.40 (m, 4 H), 7.36–7.34 (m, 4 H), 7.26 (d, J = 7.6 Hz, 2 H), 5.00 (s, 2 H). 13C NMR (125 MHz, CDCl3): δ = 166.1, 143.6, 142.1, 133.2, 132.9, 132.6, 130.7, 129.7, 129.6, 129.3, 129.0, 128.7, 127.8, 127.4, 127.2, 126.3, 122.7, 43.8. IR: 1643, 1492, 1403, 753, 695 cm–1. ESI-HRMS: m/z calcd for C22H17N4O [M + H]+: 353.1397; found: 353.1412.